Search

Purpose: To determine the prevalence of SARS-CoV-2 in tear samples and to investigate whether it correlates with ocular findings and patients’ prognosis in Brazil. Methods: Tears were collected using Schirmer strips (SS) and conjunctival swabs (CS) from patients hospitalized with laboratory-confirmed SARS-CoV-2 infection. Samples were analyzed using qRT-PCR. Demographic and clinical data, ocular symptoms, and Schirmer tests (ST) were collected from patients. Charlson Comorbidity Index (CCI) was used to rate comorbidities, and patients were monitored until hospital discharge or death. Results: There were 61 hospitalized patients, 33 of which were diagnosed with COVID-19. Within the confirmed COVID-19 patients, SARS-CoV-2 was detected in 18.2% (n = 6) of CS and 12.1% (n = 4) of SS samples. Subjective and objective parameters for dry eye syndrome (e.g., ST COVID-19: 8.3 ± 6.4mm, non-COVID-19: 8.9 ± 6.6mm, p > 0.05) were comparable between COVID-19 (n = 33) and non-COVID-19 patients (n = 28). Among the 16 COVID-19 patients exhibiting ocular symptoms, only tearing was reported significantly more frequently when tear samples were positive for SARS-CoV-2 (p < 0.05). Strikingly, patients whose tears tested positive for SARS-CoV-2 had significantly inferior CCI (pos.: 34.0 ± 31.8%, neg.: 67.6 ± 36.4%, p < 0.05) and higher mortality rates (pos.: 50.0%, neg.: 7.4%, p < 0.01). Conclusions: SARS-CoV-2 was detected with a prevalence of 18.2% on the ocular surface. Decreased CCI and increased mortality rate in the positive tear group suggests that viral detection may relate to prognosis and highlight the need of personal protective measures for healthcare professionals. Most of the patients, regardless of COVID-19 diagnosis, had low tear production and eye discomfort, possibly pointing to the need for artificial tear use during hospitalization.

Schirmer strips and conjunctival swabs are used in ophthalmology for the collection of tears and fluids. One of the biggest challenges during the COVID-19 pandemic has been accurate diagnosis and, in some cases, ocular manifestations are among the first symptoms. In this context, this study aimed to collect evidence to support the use of Schirmer strips and conjunctival swabs as a method of sample collection for viral analysis. A literature search was conducted following the Scoping Review protocol defined by The Joanna Briggs Institute. Studies were analyzed regarding virus research, collection methods, and sample analysis. The findings support that viruses can be detected on the ocular surface through analysis of Schirmer strips and conjunctival swabs. However, additional studies with larger samples and time data are necessary to confirm these conclusions.

Purpose Schirmer Strips and Conjunctival swabs are used in ophthalmology for tears and fluids collection. During the COVID-19 pandemic, one of the biggest challenges is accurate diagnosis, and it is known that, in some cases, ocular manifestations are one of the first symptoms. In this context, this study has the objective of raising scientific evidence that highlights the use of Schirmer strips and conjunctival swabs as a method of sample collection for viral analysis to support future research on this theme. Methods A literature search was conducted in the PubMed, Web of Science and BVS databases, following the Scoping Review protocol defined by Joanna Briggs Institute (JBI) after the guiding question “Is it possible to detect viruses on the ocular surface with Schirmer Test and/or conjunctival swab?”.Results A total of 418 studies were identified, and after discerning analysis, 36 English written studies were selected. Three researchers analyzed studies after virus research, collection methods, and sample analysis. Publications were mainly on adenovirus, herpes simplex virus and SARS-CoV-2, and there is also evidence of ocular detection of more viruses types. Conjuntival swab analyzed through Polymerase Chain Reaction (PCR) or Reverse Transcriptase-PCR (RT-PCR) were the most used methods.Conclusions Studies have generally been conducted to understand viral infection, to develop accurate diagnostic methods and to follow the patients’ response to treatment. Most studies were performed with a small number of patients and lacked clear definitions of collection time and viral persistence since the onset of diseases. Viruses can be detected on the ocular surface through the analysis of Schirmer strips and conjunctival swabs. However, additional studies with larger populations and time permanence are necessary to develop more assertive conclusions on the theme.

RESUMO A toxocaríase ocular pode evoluir como granuloma posterior de retina, granuloma periférico ou como endoftalmite. Seu tratamento é inicialmente clínico, entretanto, em casos de severo dano ocular, o tratamento poderá ser cirúrgico, através de vitrectomia. São relatados neste estudo, seis casos de toxocaríase ocular e descolamento de retina, com A V pré-operatória que variou de PL a movimentos de mão, e que foram submetidos à vitrectomia na tentativa de recuperação visual. Os pacientes foram divididos em dois grupos: 1 - crianças menores (7-10 anos) e com apresentação clínica com forte componente inflamatório; II - pacientes com mais idade (19-22 anos) e que apresentaram descolamento de retina por rotura gigante e granuloma por toxocaríase. Destes, apenas 2 pacientes do grupo II apresentaram significativa melhora visual. Os outros mantiveram a mesma A V pré-operatória ou pioraram, devido à ocorrência de intenso processo inflamatório no pós-operatório (P. O.)

RESUMO Quatro pacientes, sendo que um sofreu acometimento de ambos os olhos, apresentaram importante membrana de fibrina em câmara anterior, entre o primeiro e o sétimo dia pós-operatório de facectomia com implante de LIO em câmara posterior. Foram, então, submetidos a uma injeção intra-ocular em câmara anterior, de 25mcg de ativador de plasminogênio tecidual (TPA). Entre 3 e 12 horas após a aplicação deste agente fibrinolítico, houve desaparecimento completo de fibrina, sem apresentar qualquer efeito adverso.